Home Local Feds: Top U. of C. doctor used insider knowledge of cancer drug to make stock market windfall

Feds: Top U. of C. doctor used insider knowledge of cancer drug to make stock market windfall

by staff

According to the charges, Catenacci served as one of the lead physicians and primary field investigators on a clinical trial by a California-based biotechnology company, identified only as Company A. Through this position, Catenacci allegedly received confidential information about the company and its clinical trial results.

Related Articles

Leave a Comment